#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal carcinoma Ureteric cancer Arteriosclerosis Interstitial lung disease Chronic myeloid leukaemia (in remission) Oesophageal adenocarcinoma stage III Systemic sclerosis pulmonary Fabry's disease Infantile spasms Marginal zone lymphoma refractory Primary biliary cholangitis Cerebellar ataxia Metastases to peritoneum Chronic cutaneous lupus erythematosus Arrhythmia More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Life with Disease Fabry’s disease – Diagnostics Wiskott-Aldrich syndrome – Treatment Alternating hemiplegia of childhood – Trials in Disease Familial haemophagocytic lymphohistiocytosis Cerebral arteriovenous malformation haemorrhagic Lennox-Gastaut syndrome – Treatment Mucopolysaccharidosis III Combined immunodeficiency – Life with Disease Systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlorhexidine Dihydrochloride Human Coagulation Factor Viii Paracetamol Paracetamol Ph. Eur. Enoxaparin Sodium Tobevibart Abt-494 Bi-1910 Piracetam Burfiralimab Ganciclovir Sodium Asfotase Alfa Fludeoxyglucose (18F) Trazodone Iti-1284 Jnj-64042056 Auto4 Ammonium Chloride Bp Ribitol Afm24 More therapies…

    Learn about Your Condition

    Plasma cell myeloma recurrent Atrial fibrillation Anal squamous cell carcinoma Uterine leiomyosarcoma Thrombocytosis Merycism Behavioural addiction Thyroid mass Pleural mesothelioma Peritoneal abscess Inflammation Allergic respiratory disease Hypotension Synovial sarcoma recurrent Ureteric cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A study of progesterone after letrozole treatment for women with infertility undergoing intrauterine insemination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Progesterone
    Denmark

  • A study of upadacitinib in adults with erosive mucosal lichen planus and lichen planopilaris.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Lichen planus
    Investigated Drugs:
    • Upadacitinib
    France

  • Study of the effect of dapagliflozin on the development of post-transplant diabetes in kidney transplant recipients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Dapagliflozin
    Denmark

  • Study of the effectiveness of iloprost compared to a placebo for treating vaso-occlusive crises in adults with sickle cell disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • ILOPROST
    • Glucose Monohydrate
    France

  • A study of allogeneic adipose-derived mesenchymal stem cells for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • ALLOGENEIC ADIPOSE-DERIVED MESENCHYMAL STEM CELLS IN VITRO EXPANDED
    Denmark

  • A study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Zasocitinib
    France Germany The Netherlands Poland
Previous Page
1 … 735 736 737 738 739 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!